InvestorsHub Logo
Followers 99
Posts 5437
Boards Moderated 3
Alias Born 08/08/2018

Re: None

Friday, 01/17/2020 7:24:04 PM

Friday, January 17, 2020 7:24:04 PM

Post# of 742
ASRT: Breakout!!
ASRT: Assertio Therapeutics Inc, formerly known as "Depomed" is positioned for a major breakout, a minimum of 50% upside immediately with a 6-10 times multiples of current stock price is brewing up!!..Why?
The company has FDA approved products, recently restructured some of its products line "GABAPentine", this deal brings 100plus Million including 75million in cash, putting companies cash position and evaluation higher than prior one's, also the company provided future estimates topping any and all estimates!....that means Breakout!!!

deal: ""Alvogen will pay Assertio a total value of $127.5 million. This includes $75.0 million in cash upon closing and the balance payable in the form of a royalty on the first $70.0 million in Gralise net sales. Both companies expect the majority of the royalties to be paid in the first calendar year. Assertio also entered into an amendment to its senior secured credit agreement to facilitate the transactions described above""

https://www.barchart.com/story/stocks/quotes/ASRT/overview/4214827/assertio-therapeutics-announces-closing-of-graliser-sale-to-alvogen-and-expects-full-year-2019-neurology-franchise-net-sales-above-upper-end-of-prior-guidance


Assertio Therapeutics Inc (ASRT)
1.24 +0.03 (+2.48%) 01/17/20 [NASDAQ]
1.26 x 1 1.27 x 6 Post-market 1.27 +0.03 (+2.42%) 16:54 ET
Quote Overview for Fri, Jan 17th, 2020

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.